Enterocolitis is the most commonly reported adverse effect, occurring in 12.3% of patients; hypophysitis occurs as the second most frequent toxicity in 5% of the patients.4,5 CTLA-4 gene knock-out mice develop lymphoproliferative and autoimmune disorders.6 Here, CTLA4 is linked to hypophysitis.